<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fletcher-Sandersjoo A</submitter><funding>Svenska Sällskapet för Medicinsk Forskning</funding><pagination>548</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6043665</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9</volume><pubmed_abstract>&lt;b>Background:&lt;/b> Intracranial hemorrhage (ICH) is a common complication in adults treated with extracorporeal membrane oxygenation (ECMO). &lt;b>Objectives:&lt;/b> The aim of this study was to conduct a systematic review of the literature on the incidence, outcome and predictors of ECMO-associated ICH in adult patients, supplemented by a narrative review of its pathophysiology, management and future perspectives. &lt;b>Methods:&lt;/b> MEDLINE, EMBASE, Cochrane Database of Systematic Reviews and www.clinicaltrials.gov were systematically searched. Studies that reported incidence, outcome or predictors of ECMO-associated ICH in adults (≥18 years) were eligible for inclusion. &lt;b>Results:&lt;/b> Twenty five articles were included in the systematic review. The incidence of ECMO-associated ICH varied between 1.8 and 21 %. Mortality rates in ICH-cohorts varied between 32 and 100 %, with a relative risk of mortality of 1.27-4.43 compared to non-ICH cohorts. An increased risk of ICH was associated with ECMO-duration, antithrombotic therapy, altered intrinsic coagulation, renal failure, need of blood products, rapid hypercapnia at ECMO initiation, and even pre-ECMO morbidity. &lt;b>Conclusions:&lt;/b> ICH is a common complication in adults treated with ECMO and associated with increased mortality. Treating an ICH during ECMO represents a balance between pro- and anticoagulatory demands. Neurosurgical treatment is associated with severe morbidity, but has been successful in selected cases. Future studies should aim at investigating the validity and feasibility of non-invasive monitoring in early detection of ECMO-associated ICH.</pubmed_abstract><journal>Frontiers in neurology</journal><pubmed_title>Incidence, Outcome, and Predictors of Intracranial Hemorrhage in Adult Patients on Extracorporeal Membrane Oxygenation: A Systematic and Narrative Review.</pubmed_title><pmcid>PMC6043665</pmcid><funding_grant_id>SLS- 587221</funding_grant_id><pubmed_authors>Elmi-Terander A</pubmed_authors><pubmed_authors>Thelin EP</pubmed_authors><pubmed_authors>Sallisalmi M</pubmed_authors><pubmed_authors>Broman M</pubmed_authors><pubmed_authors>Bellander BM</pubmed_authors><pubmed_authors>Fletcher-Sandersjoo A</pubmed_authors><pubmed_authors>Bartek J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Incidence, Outcome, and Predictors of Intracranial Hemorrhage in Adult Patients on Extracorporeal Membrane Oxygenation: A Systematic and Narrative Review.</name><description>&lt;b>Background:&lt;/b> Intracranial hemorrhage (ICH) is a common complication in adults treated with extracorporeal membrane oxygenation (ECMO). &lt;b>Objectives:&lt;/b> The aim of this study was to conduct a systematic review of the literature on the incidence, outcome and predictors of ECMO-associated ICH in adult patients, supplemented by a narrative review of its pathophysiology, management and future perspectives. &lt;b>Methods:&lt;/b> MEDLINE, EMBASE, Cochrane Database of Systematic Reviews and www.clinicaltrials.gov were systematically searched. Studies that reported incidence, outcome or predictors of ECMO-associated ICH in adults (≥18 years) were eligible for inclusion. &lt;b>Results:&lt;/b> Twenty five articles were included in the systematic review. The incidence of ECMO-associated ICH varied between 1.8 and 21 %. Mortality rates in ICH-cohorts varied between 32 and 100 %, with a relative risk of mortality of 1.27-4.43 compared to non-ICH cohorts. An increased risk of ICH was associated with ECMO-duration, antithrombotic therapy, altered intrinsic coagulation, renal failure, need of blood products, rapid hypercapnia at ECMO initiation, and even pre-ECMO morbidity. &lt;b>Conclusions:&lt;/b> ICH is a common complication in adults treated with ECMO and associated with increased mortality. Treating an ICH during ECMO represents a balance between pro- and anticoagulatory demands. Neurosurgical treatment is associated with severe morbidity, but has been successful in selected cases. Future studies should aim at investigating the validity and feasibility of non-invasive monitoring in early detection of ECMO-associated ICH.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018</publication><modification>2024-12-03T15:57:22.113Z</modification><creation>2019-03-26T23:47:23Z</creation></dates><accession>S-EPMC6043665</accession><cross_references><pubmed>30034364</pubmed><doi>10.3389/fneur.2018.00548</doi></cross_references></HashMap>